BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

NEWS: BDSI Completes Acquisition of ELYXYB Learn More >
TECHNOLOGY

Patient-centric Technology

Advancing innovation to enhance treatment

BDSI helps develop technologies designed to deliver increased bioavailability in the treatment of serious and debilitating chronic conditions.

BioErodible MucoAdhesive (BEMA®) Technology

BioErodible MucoAdhesive (BEMA®) technology uses a small polymer film applied to the inner lining of the cheek for rapid drug administration. Delivering medication across the mucous membranes, this bioerodible film helps optimize time-sensitive treatments. It is also beneficial for facilitating the administration of drugs where poor oral absorption is an issue.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, 1-800-FDA-1088. Report an Adverse Event

Recent BDSI News

November 3, 2021

Total Net Revenue of $41.1 Million , an Increase of 4% versus Prior Year Strong profitability with GAAP EPS of $0.07 , EBITDA Margin of 27% and $7.0 million Operating Cash Flow Closed acquisition of ELYXYB, the first FDA-approved, ready-to-use oral solution for acute migraine with potential

Read more
October 21, 2021

RALEIGH, N.C. , Oct. 21, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions, today announced the appointment of John Golubieski as Chief Financial

Read more
October 20, 2021

RALEIGH, N.C. , Oct. 20, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, announced today that it will report its third quarter 2021 financial results before the open of

Read more
More news

Upcoming Events

There are no events to display

Stay Connected

Stay up to date on the latest news

Get started now
November 29, 2021BDSI $2.82/ - -3.09%
Data provided by Nasdaq. Minimum 15 minutes delayed.